The same stem cells can help one brain disease and do nothing for another. The difference is not the cells—it is the mechanism.

Neural stem cells, MSCs, iPSC-derived neurons—we are injecting them into patients with ALS, MS, Parkinsons, Alzheimers, and spinal cord injury. What is becoming clear: a therapy that works in one condition often fails in another. The mechanism matters more than the cell type.